In the absence of medicinesthe map of shortage of the Pharmaceutical Institute of Mexico warned that, in January 2016, the psychiatric medications they registered a 98 percent supply in public health institutions; for January 2022the supply of these drugs fell to 64 percentwarned the senator Claudia Ruiz Massieu.
Through an exhortation to the Ministry of Health, the PRI requested that through the Federal Commission for the Protection once morest Sanitary Risks (cofepris) submit a report on the options it has prepared to deal with the shortage of drugs, particularly psychiatric ones.
In order to face the shortage of psychiatric drugs due to the suspension of activities of the pharmaceutical company Psychopharmaceuticala 100 percent Mexican company that was the only supplier to the Federal Government, made an urgent call to the Health Secretary to carry out the necessary actions and ensure the timely and sufficient supply of psychiatric medications in Mexico.
The warrant states that following the COVID-19 pandemicThousands of people have seen their mental health affected in Mexico. Anxiety and depression disorders increased by more than 25 percent during the first year of the pandemic, and 35 percent in the second, falling to 39 percent by 2022.
In addition, 23 percent of the population have the symptoms of Post Traumatic Stress Disorders and 31 percent of children have sleep disorders, depression and anxiety upon their return to school in the 2022-2023 cycle.
In this scenario of increased demand for psychiatric medical care to treat these conditions, there has been a significant shortage of psychiatric medications since 2021, which has worsened particularly in recent months. This lack of medicines has not only occurred in the public sector, but also in the private sector, affecting thousands of Mexicans, whose health is put at risk,” warned Ruíz Massieu.
The PRI senator warned that shortages of medicines to treat psychiatric and neurological diseases have been reported in 11 entities, both in public hospitals and in private sector pharmacies: Tamaulipas. Baja California, Zacatecas, San Luis Potosí, Morelos, Jalisco, Hidalgo, Durango, Aguascalientes and Chihuahua.
In addition, he also asked to review the operation of the subsystems of the National Health System (IMSS, ISSSTE, Pemex, Sedena and Semar) in terms of unfilled prescriptions, since the number of cases has been increasing.
It was noted that in 2019, 5,40,111 prescriptions were not filled, a figure that tripled in 2020 with 15,857,785 and increased to just over 22 million by 2021.
With information from López-Dóriga Digital
